| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cleft Palate | 16 | 2019 | 40 | 2.720 |
Why?
|
| Cleft Lip | 11 | 2019 | 24 | 1.900 |
Why?
|
| Genomic Imprinting | 16 | 2015 | 49 | 1.690 |
Why?
|
| Neural Tube Defects | 15 | 2022 | 28 | 1.680 |
Why?
|
| Sorting Nexins | 3 | 2020 | 3 | 1.640 |
Why?
|
| Placenta | 6 | 2020 | 69 | 1.340 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2020 | 12 | 1.200 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 225 | 1.050 |
Why?
|
| DNA Methylation | 12 | 2019 | 306 | 0.930 |
Why?
|
| Mutation | 18 | 2018 | 2666 | 0.800 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2018 | 663 | 0.700 |
Why?
|
| T-Box Domain Proteins | 4 | 2009 | 38 | 0.680 |
Why?
|
| Cell Polarity | 5 | 2022 | 110 | 0.670 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 3 | 2017 | 5 | 0.670 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2019 | 734 | 0.660 |
Why?
|
| Fetal Viability | 1 | 2020 | 6 | 0.650 |
Why?
|
| Fibroblast Growth Factors | 2 | 2012 | 77 | 0.610 |
Why?
|
| Epigenesis, Genetic | 7 | 2019 | 410 | 0.600 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2015 | 23 | 0.600 |
Why?
|
| Craniofacial Abnormalities | 2 | 2017 | 23 | 0.580 |
Why?
|
| Mutation, Missense | 8 | 2019 | 190 | 0.560 |
Why?
|
| SUMO-1 Protein | 4 | 2017 | 8 | 0.550 |
Why?
|
| Abnormalities, Multiple | 5 | 2016 | 54 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 7 | 2022 | 428 | 0.520 |
Why?
|
| Palate | 3 | 2012 | 7 | 0.520 |
Why?
|
| Phenotype | 10 | 2021 | 1233 | 0.520 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 177 | 0.510 |
Why?
|
| Sumoylation | 1 | 2017 | 17 | 0.500 |
Why?
|
| Signal Transduction | 5 | 2017 | 3155 | 0.490 |
Why?
|
| Alleles | 14 | 2018 | 454 | 0.470 |
Why?
|
| Birth Weight | 5 | 2018 | 83 | 0.450 |
Why?
|
| Fetal Development | 1 | 2015 | 14 | 0.450 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 226 | 0.440 |
Why?
|
| Choanal Atresia | 2 | 2017 | 3 | 0.440 |
Why?
|
| Cerebellar Ataxia | 1 | 2014 | 13 | 0.430 |
Why?
|
| Animals | 39 | 2022 | 21381 | 0.410 |
Why?
|
| Membrane Proteins | 5 | 2015 | 924 | 0.400 |
Why?
|
| Humans | 62 | 2021 | 65463 | 0.400 |
Why?
|
| Lip | 2 | 2016 | 12 | 0.400 |
Why?
|
| Forkhead Transcription Factors | 2 | 2019 | 132 | 0.390 |
Why?
|
| Preconception Injuries | 1 | 2013 | 1 | 0.390 |
Why?
|
| Nitrogenous Group Transferases | 3 | 2019 | 3 | 0.390 |
Why?
|
| Fathers | 1 | 2013 | 22 | 0.380 |
Why?
|
| Cadherins | 2 | 2017 | 90 | 0.380 |
Why?
|
| Language Disorders | 1 | 2012 | 25 | 0.370 |
Why?
|
| Ubiquitins | 1 | 2012 | 41 | 0.360 |
Why?
|
| Transcription Factors | 8 | 2019 | 1557 | 0.360 |
Why?
|
| Spinal Dysraphism | 4 | 2018 | 18 | 0.360 |
Why?
|
| Speech | 1 | 2012 | 63 | 0.360 |
Why?
|
| Intellectual Disability | 1 | 2014 | 176 | 0.360 |
Why?
|
| Mice | 30 | 2022 | 11138 | 0.350 |
Why?
|
| Lingual Frenum | 2 | 2009 | 4 | 0.350 |
Why?
|
| Pregnancy | 11 | 2020 | 2390 | 0.340 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 210 | 0.340 |
Why?
|
| Fetus | 8 | 2015 | 103 | 0.320 |
Why?
|
| DNA-Binding Proteins | 6 | 2018 | 1225 | 0.320 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2007 | 10 | 0.310 |
Why?
|
| Embryonic Development | 4 | 2020 | 142 | 0.280 |
Why?
|
| Base Sequence | 10 | 2014 | 1331 | 0.280 |
Why?
|
| Female | 32 | 2020 | 34193 | 0.280 |
Why?
|
| Zebrafish | 4 | 2020 | 374 | 0.270 |
Why?
|
| Sequence Analysis, DNA | 8 | 2014 | 414 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 8 | 2017 | 687 | 0.270 |
Why?
|
| Abortion, Habitual | 2 | 2019 | 8 | 0.270 |
Why?
|
| Heterozygote | 6 | 2018 | 173 | 0.260 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 22 | 0.260 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1979 | 0.260 |
Why?
|
| Bone and Bones | 2 | 2018 | 152 | 0.250 |
Why?
|
| Trophoblasts | 2 | 2020 | 9 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 268 | 0.240 |
Why?
|
| Pedigree | 6 | 2019 | 193 | 0.230 |
Why?
|
| Immunoglobulins | 2 | 2003 | 74 | 0.230 |
Why?
|
| Male | 26 | 2019 | 31187 | 0.220 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 312 | 0.220 |
Why?
|
| Chorionic Villi | 2 | 2015 | 2 | 0.220 |
Why?
|
| Obesity | 1 | 2013 | 1275 | 0.210 |
Why?
|
| Genotype | 5 | 2018 | 674 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 7 | 4 | 2008 | 13 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3488 | 0.200 |
Why?
|
| Folic Acid | 4 | 2013 | 42 | 0.190 |
Why?
|
| Fetal Growth Retardation | 3 | 2018 | 21 | 0.190 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 410 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2005 | 413 | 0.190 |
Why?
|
| Proteins | 7 | 2008 | 764 | 0.180 |
Why?
|
| HEK293 Cells | 3 | 2019 | 617 | 0.180 |
Why?
|
| Embryo, Mammalian | 4 | 2009 | 158 | 0.180 |
Why?
|
| Syndrome | 6 | 2019 | 180 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 138 | 0.170 |
Why?
|
| Nevus | 1 | 2021 | 23 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 512 | 0.170 |
Why?
|
| Chromosome Mapping | 4 | 2014 | 296 | 0.170 |
Why?
|
| Craniosynostoses | 2 | 2018 | 11 | 0.160 |
Why?
|
| Hyperostosis | 2 | 2018 | 3 | 0.160 |
Why?
|
| Penetrance | 2 | 2017 | 11 | 0.160 |
Why?
|
| Aneuploidy | 2 | 2015 | 42 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 81 | 0.160 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2019 | 2 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2019 | 10 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 542 | 0.150 |
Why?
|
| Models, Animal | 1 | 2020 | 242 | 0.150 |
Why?
|
| Child | 8 | 2019 | 4623 | 0.150 |
Why?
|
| Short Rib-Polydactyly Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 2019 | 1 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 790 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 5 | 0.140 |
Why?
|
| Craniofacial Dysostosis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2019 | 394 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 1 | 2018 | 19 | 0.140 |
Why?
|
| Oleic Acid | 1 | 2018 | 20 | 0.140 |
Why?
|
| Fibroblasts | 4 | 2014 | 422 | 0.140 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cutis Laxa | 1 | 2018 | 8 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 97 | 0.140 |
Why?
|
| Lipid Droplets | 1 | 2018 | 35 | 0.140 |
Why?
|
| Neural Tube | 3 | 2022 | 12 | 0.130 |
Why?
|
| Melanoma | 1 | 2021 | 333 | 0.130 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2017 | 8 | 0.130 |
Why?
|
| In Situ Hybridization | 3 | 2009 | 213 | 0.130 |
Why?
|
| Cohort Studies | 5 | 2018 | 2633 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 174 | 0.130 |
Why?
|
| Cor Triatriatum | 1 | 2017 | 3 | 0.130 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2017 | 6 | 0.130 |
Why?
|
| Endosomes | 1 | 2018 | 180 | 0.130 |
Why?
|
| Deafness | 1 | 2017 | 36 | 0.120 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 2305 | 0.120 |
Why?
|
| Premature Birth | 1 | 2018 | 116 | 0.120 |
Why?
|
| Databases as Topic | 1 | 2016 | 49 | 0.120 |
Why?
|
| Genes, Recessive | 2 | 2014 | 51 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1631 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 95 | 0.120 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 23 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 101 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2017 | 312 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 446 | 0.120 |
Why?
|
| Nevus, Pigmented | 2 | 2013 | 20 | 0.120 |
Why?
|
| Open Reading Frames | 1 | 2016 | 84 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2007 | 363 | 0.120 |
Why?
|
| Microbiota | 1 | 2018 | 169 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 237 | 0.120 |
Why?
|
| Annexin A5 | 1 | 2015 | 20 | 0.110 |
Why?
|
| Homeostasis | 1 | 2018 | 380 | 0.110 |
Why?
|
| CpG Islands | 4 | 2017 | 219 | 0.110 |
Why?
|
| GRB10 Adaptor Protein | 4 | 2009 | 4 | 0.110 |
Why?
|
| Receptors, Somatomedin | 1 | 2015 | 10 | 0.110 |
Why?
|
| Haplotypes | 1 | 2015 | 135 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2018 | 2162 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2015 | 47 | 0.110 |
Why?
|
| Bacteria | 1 | 2018 | 336 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1387 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1143 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 94 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 1588 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 254 | 0.100 |
Why?
|
| Brain | 2 | 2015 | 1611 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 62 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 156 | 0.100 |
Why?
|
| Gene Expression | 3 | 2012 | 854 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 449 | 0.100 |
Why?
|
| Skull | 2 | 2018 | 52 | 0.100 |
Why?
|
| Lamin Type B | 1 | 2013 | 4 | 0.100 |
Why?
|
| Introns | 2 | 2012 | 114 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 160 | 0.100 |
Why?
|
| Exons | 4 | 2018 | 208 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 571 | 0.100 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2013 | 9 | 0.100 |
Why?
|
| Melanosis | 1 | 2013 | 10 | 0.100 |
Why?
|
| Child, Preschool | 5 | 2018 | 2066 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2018 | 1431 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 515 | 0.090 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2012 | 9 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2012 | 1 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 64 | 0.090 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2012 | 1 | 0.090 |
Why?
|
| Aminomethyltransferase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Glycine Decarboxylase Complex H-Protein | 1 | 2011 | 1 | 0.090 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2011 | 2 | 0.090 |
Why?
|
| Gene Order | 1 | 2011 | 33 | 0.090 |
Why?
|
| Computational Biology | 2 | 2013 | 368 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 389 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 128 | 0.090 |
Why?
|
| Risk Factors | 3 | 2017 | 5458 | 0.090 |
Why?
|
| Collectins | 1 | 2011 | 4 | 0.080 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2011 | 4 | 0.080 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2011 | 5 | 0.080 |
Why?
|
| Cell Line | 3 | 2011 | 2024 | 0.080 |
Why?
|
| Dogs | 1 | 2011 | 315 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 405 | 0.080 |
Why?
|
| Silver-Russell Syndrome | 1 | 2010 | 1 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 2005 | 301 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 154 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 796 | 0.080 |
Why?
|
| Adult | 7 | 2018 | 17461 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 33 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2009 | 204 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 37 | 0.070 |
Why?
|
| Body Patterning | 1 | 2008 | 94 | 0.070 |
Why?
|
| Chromosomes, Mammalian | 2 | 2008 | 33 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2008 | 433 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2002 | 165 | 0.070 |
Why?
|
| Facies | 2 | 2018 | 9 | 0.070 |
Why?
|
| Facial Bones | 1 | 2007 | 10 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2007 | 22 | 0.060 |
Why?
|
| DNA | 3 | 2007 | 852 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 251 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2008 | 189 | 0.060 |
Why?
|
| Myopathy, Central Core | 1 | 2006 | 1 | 0.060 |
Why?
|
| DNA Primers | 4 | 2014 | 301 | 0.060 |
Why?
|
| Azacitidine | 2 | 2006 | 15 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 491 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 350 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2006 | 45 | 0.060 |
Why?
|
| Point Mutation | 1 | 2006 | 168 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 72 | 0.060 |
Why?
|
| Models, Biological | 2 | 2009 | 1192 | 0.060 |
Why?
|
| United Kingdom | 2 | 2018 | 85 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2008 | 351 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 907 | 0.060 |
Why?
|
| Notochord | 1 | 2005 | 9 | 0.060 |
Why?
|
| Neural Crest | 2 | 2018 | 30 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 706 | 0.060 |
Why?
|
| Homozygote | 2 | 2017 | 122 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 385 | 0.050 |
Why?
|
| Maxillofacial Development | 1 | 2004 | 3 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2188 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2003 | 30 | 0.050 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2003 | 4 | 0.050 |
Why?
|
| Viscera | 1 | 2003 | 10 | 0.050 |
Why?
|
| Peripheral Nervous System | 1 | 2003 | 12 | 0.050 |
Why?
|
| Dopa Decarboxylase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Adolescent | 4 | 2017 | 6332 | 0.050 |
Why?
|
| Gene Duplication | 1 | 2002 | 35 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 153 | 0.050 |
Why?
|
| Epithelium | 1 | 2003 | 100 | 0.050 |
Why?
|
| Synteny | 1 | 2002 | 24 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 718 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 23 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2002 | 50 | 0.050 |
Why?
|
| Histones | 3 | 2011 | 495 | 0.040 |
Why?
|
| Nervous System | 1 | 2002 | 71 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2002 | 300 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 54 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 277 | 0.040 |
Why?
|
| Stem Cells | 1 | 2003 | 276 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2003 | 200 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2017 | 342 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1039 | 0.040 |
Why?
|
| Palate, Soft | 1 | 2019 | 3 | 0.040 |
Why?
|
| Uvula | 1 | 2019 | 2 | 0.040 |
Why?
|
| Incidence | 1 | 2004 | 1430 | 0.040 |
Why?
|
| Pharynx | 1 | 2019 | 25 | 0.040 |
Why?
|
| Exome | 1 | 2019 | 69 | 0.040 |
Why?
|
| Netrin-1 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 897 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 12 | 0.040 |
Why?
|
| Cranial Sutures | 1 | 2018 | 4 | 0.040 |
Why?
|
| Congenital Microtia | 1 | 2018 | 2 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 23 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 260 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2018 | 46 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 198 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2018 | 21 | 0.030 |
Why?
|
| PAX3 Transcription Factor | 1 | 2018 | 12 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 1451 | 0.030 |
Why?
|
| Transgenes | 1 | 2019 | 207 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 105 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 181 | 0.030 |
Why?
|
| Vagina | 1 | 2018 | 87 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2008 | 99 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 73 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2019 | 282 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 541 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 120 | 0.030 |
Why?
|
| Gestational Age | 1 | 2018 | 194 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 138 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 103 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 235 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 38 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 171 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 261 | 0.030 |
Why?
|
| Neurons | 1 | 2003 | 934 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2018 | 150 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2018 | 218 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2008 | 1575 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2010 | 115 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 61 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 364 | 0.030 |
Why?
|
| Cysts | 1 | 2016 | 44 | 0.030 |
Why?
|
| Radiography | 1 | 2018 | 558 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 124 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2008 | 321 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 15 | 0.030 |
Why?
|
| Dwarfism | 1 | 2013 | 16 | 0.030 |
Why?
|
| Photobleaching | 1 | 2013 | 3 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 8 | 0.020 |
Why?
|
| Nuclear Lamina | 1 | 2013 | 10 | 0.020 |
Why?
|
| Sweden | 1 | 2013 | 64 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 12 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 211 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 25 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2013 | 184 | 0.020 |
Why?
|
| Mosaicism | 1 | 2013 | 29 | 0.020 |
Why?
|
| Zygote | 1 | 2013 | 45 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 93 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 185 | 0.020 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 39 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 62 | 0.020 |
Why?
|
| Meningioma | 1 | 2013 | 64 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 47 | 0.020 |
Why?
|
| Glycine Decarboxylase Complex | 1 | 2011 | 1 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 59 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 85 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 38 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 22 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1008 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 44 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3324 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 887 | 0.020 |
Why?
|
| Aborted Fetus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2011 | 266 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 482 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 41 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 285 | 0.020 |
Why?
|
| Mitotic Index | 1 | 2007 | 2 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2007 | 19 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 152 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 324 | 0.020 |
Why?
|
| Anencephaly | 1 | 2007 | 1 | 0.020 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 1 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 2007 | 3 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2007 | 3 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2007 | 18 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1703 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1170 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 31 | 0.020 |
Why?
|
| Methylation | 1 | 2007 | 130 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 12 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 29 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 198 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 293 | 0.010 |
Why?
|
| Sulfites | 1 | 2003 | 5 | 0.010 |
Why?
|
| Gene Components | 1 | 2003 | 5 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 56 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2003 | 49 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1290 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 116 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2003 | 48 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 2250 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 133 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 90 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 111 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1098 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 80 | 0.010 |
Why?
|
| Genes | 1 | 2003 | 90 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 111 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 44 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 173 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 173 | 0.010 |
Why?
|
| Karyotyping | 1 | 2002 | 48 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 142 | 0.010 |
Why?
|
| Lac Operon | 1 | 2002 | 26 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4837 | 0.010 |
Why?
|
| DNA Modification Methylases | 1 | 2002 | 18 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 97 | 0.010 |
Why?
|
| Middle Aged | 2 | 2010 | 18387 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 152 | 0.010 |
Why?
|
| X Chromosome | 1 | 2002 | 52 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 161 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 116 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2002 | 128 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 339 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 201 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 204 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 171 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 513 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 450 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 868 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 787 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 345 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 398 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 367 | 0.010 |
Why?
|
| Genome | 1 | 2003 | 285 | 0.010 |
Why?
|
| United States | 1 | 2013 | 8148 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 15052 | 0.010 |
Why?
|